بدائل البحث:
complement component » complex components (توسيع البحث)
using algorithm » using algorithms (توسيع البحث), routing algorithm (توسيع البحث), fusion algorithm (توسيع البحث)
data algorithm » data algorithms (توسيع البحث), update algorithm (توسيع البحث), atlas algorithm (توسيع البحث)
element data » settlement data (توسيع البحث), relevant data (توسيع البحث), movement data (توسيع البحث)
complement component » complex components (توسيع البحث)
using algorithm » using algorithms (توسيع البحث), routing algorithm (توسيع البحث), fusion algorithm (توسيع البحث)
data algorithm » data algorithms (توسيع البحث), update algorithm (توسيع البحث), atlas algorithm (توسيع البحث)
element data » settlement data (توسيع البحث), relevant data (توسيع البحث), movement data (توسيع البحث)
-
21
-
22
-
23
-
24
The mAP for all algorithms and 80% of the data used for training.
منشور في 2024"…<p>The mAP for all algorithms and 80% of the data used for training.</p>…"
-
25
The mAP for all algorithms and 50% of the data used for training.
منشور في 2024"…<p>The mAP for all algorithms and 50% of the data used for training.</p>…"
-
26
The mAP for all algorithms and 60% of the data used for training.
منشور في 2024"…<p>The mAP for all algorithms and 60% of the data used for training.</p>…"
-
27
Point cloud data registration using the original ICP algorithm.
منشور في 2025"…<p>Point cloud data registration using the original ICP algorithm.…"
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
Registered and fused point cloud data using improved ICP algorithm.
منشور في 2025"…<p>Registered and fused point cloud data using improved ICP algorithm.</p>…"
-
38
-
39
-
40
Four major algorithms used for signal detection.
منشور في 2024"…<div><p>Background</p><p>Due to the limitations of clinical trials, some delayed and rare adverse events (AEs) may remain undetected, and safety information can be supplemented through post-market data analysis. This study aims to comprehensively analyze the AEs associated with Relugolix (Orgovyx<sup>®</sup>) using data from the FAERS database, and gain a better understanding of the potential risks and side effects of Relugolix (Orgovyx<sup>®</sup>) therapy.…"